Trial Profile
Investigation of adverse events in long-term administration of vonoprazan for patients with gastroesophageal reflux disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2017
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions
- 03 Feb 2017 Status changed from not yet recruiting to discontinued.
- 27 May 2016 New trial record